Is combined androgen and gonadotropin therapy a viable harm reduction strategy for men using high-dose exogenous androgens who are interested in family building?
Saved in:
| Main Authors: | Evan J. Panken, M.D., Joshua A. Halpern, M.D., M.S. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | F&S Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666334125000595 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of human chorionic gonadotropin hormone in restoring spermatogenesis in men using non-prescribed androgens: a retrospective analysis of real-world data
by: Diederik L. Smit, M.D., Ph.D., et al.
Published: (2025-06-01) -
The urgency of the androgenic screening for men who underwent preventive medical examination for prostate diseases detection
by: A. A. Kamalov, et al.
Published: (2012-12-01) -
Androgen deficiency in men with chronic obstructive pulmonary disease
by: Valery I. Podzolkov, et al.
Published: (2022-03-01) -
PERSONALIZED APPROACH TO THE ASSESSMENT OF THE ANDROGENIC STATUS OF MEN WITH RAMEX
by: P. V. Glybochko, et al.
Published: (2012-09-01) -
Intermittent androgen therapy in prostate cancer reveals the pro-apoptotic roles of androgen/androgen receptor: an overview
by: Saleh Altuwaijri, et al.
Published: (2025-03-01)